Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2022 May 24;30(7):2640. doi: 10.1016/j.ymthe.2022.03.017

Retraction Notice to: METTL14 Suppresses CRC Progression via Regulating N6-Methyladenosine-Dependent Primary miR-375 Processing

Xiaoxiang Chen, Mu Xu, Xueni Xu, Kaixuan Zeng, Xiangxiang Liu, Li Sun, Bei Pan, Bangshun He, Yuqin Pan, Huiling Sun, Xinyi Xia ∗∗, Shukui Wang
PMCID: PMC9263224  PMID: 35797982

Main text

(Molecular Therapy 28, 599–612, February 2020)

Molecular Therapy is retracting this article. After receiving an email from one of the authors, evidence for image duplication in identical or altered fashion in Figures 2D, 3D, 4B, 4C, 4D, 8C, S2A, S2C, S3A, S3B, S3C, S4A, and S4C was identified. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. The authors do not agree to the retraction.

Contributor Information

Xinyi Xia, Email: xiaxynju@163.com.

Shukui Wang, Email: sk_wang@njmu.edu.cn.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES